{"id":36575,"date":"2021-04-08T21:32:51","date_gmt":"2021-04-08T21:32:51","guid":{"rendered":"https:\/\/www.xatakaciencia.com\/medicina\/300-medicamentos-pueden-causar-trombosis-muchos-ellos-mayor-probabilidad-que-astrazeneca"},"modified":"2021-04-08T21:32:51","modified_gmt":"2021-04-08T21:32:51","slug":"mas-de-300-medicamentos-pueden-causar-trombosis-muchos-de-ellos-con-mayor-probabilidad-que-astrazeneca","status":"publish","type":"post","link":"https:\/\/forocilac.org\/en\/mas-de-300-medicamentos-pueden-causar-trombosis-muchos-de-ellos-con-mayor-probabilidad-que-astrazeneca\/","title":{"rendered":"More than 300 drugs can cause thrombosis, many of them more likely than AstraZeneca"},"content":{"rendered":"<p>\n      <img decoding=\"async\" src=\"https:\/\/i.blogs.es\/06bfd9\/coronavirus-6119178_640\/1024_2000.png\" alt=\"M\u00e1s de 300 medicamentos pueden causar trombosis, muchos de ellos con mayor probabilidad que AstraZeneca\">\n    <\/p>\n<p>Following the suspicions that thrombosis has been raised after the administration of the AstraZeneca vaccine, it is worth remembering that several hundred drugs have been linked to the <strong>drug-induced thrombocytopenia<\/strong> (TCPIF). TCPIF patients have a decrease in platelet count 5 to 10 days after drug administration with an increased risk of bleeding. <\/p>\n<p><!-- BREAK 1 --><\/p>\n<p>Diagnosis, furthermore, is often challenging, because most hospitalized patients take multiple medications and have comorbidities that can also cause thrombocytopenia.<\/p>\n<p><!-- BREAK 2 --><!--more--><\/p>\n<h2>Heparin<\/h2>\n<p>The European Medicines Agency (EMA) has announced that <a href=\"https:\/\/www.ema.europa.eu\/en\/news\/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood\">it is possible to associate<\/a> rare cases of blood clots and low levels of blood platelets with the AstraZeneca vaccine, so it should appear as a &quot;very rare&quot; side effect, with a probability of &lt;1\/10,000.<\/p>\n<p><!-- BREAK 3 --><\/p>\n<div class=\"article-asset-video article-asset-large\">\n<div class=\"asset-content\">\n<div class=\"base-asset-video\">\n<div class=\"js-dailymotion\">\n    <script type=\"application\/json\">\n     {\"videoId\":\"x7zji6q\",\"autoplay\":true,\"title\":\"Cua\u0301nto dura la INMUNIDAD si has pasado el COVID19 o te acabas de VACUNAR\"}\n    <\/script>\n   <\/div><\/div><\/div>\n<\/div>\n<p>The first cases of thrombosis after vaccination with AstraZeneca <strong>were detected between 3 and 14 days after dosing<\/strong>. The patients presented a &quot;very intense headache that worsened when lying down and did not improve with analgesics&quot;, there were even cases that also presented &quot;vomiting or irregular bleeding.&quot; This last condition is what is known clinically as thrombocytopenia.<\/p>\n<p><!-- BREAK 4 --><\/p>\n<p><strong>More than 300 drugs have been implicated in TCPIF<\/strong>. A <a href=\"https:\/\/ashpublications.org\/hematology\/article\/2018\/1\/576\/277620\/Drug-associated-thrombocytopenia\">systematic review<\/a> of individual patient data found that the most frequently reported drugs with a definite or probable causal relationship with thrombocytopenia were quinine, quinidine, trimethoprim\/sulfamethoxazole, vancomycin, penicillin, rifampin, carbamazepine, ceftriaxone, ibuprofen, mirtazapine, oxaliplatin. as well as the glycoprotein IIb\/IIIa (GPIIb\/IIa) inhibitors abciximab, Tirofiban, and eptifibatide.<\/p>\n<p><!-- BREAK 5 --><\/p>\n<div class=\"article-asset article-asset-normal article-asset-center\">\n<div class=\"desvio-container\">\n<div class=\"desvio\">\n<div class=\"desvio-figure js-desvio-figure\">\n    <a href=\"https:\/\/www.xataka.com\/medicina-y-salud\/espana-deja-vacunar-astrazeneca-a-menores-60-nadie-sabe-que-ocurrira-que-han-recibido-dosis\"  ><br \/>\n     <img decoding=\"async\" alt=\"Espa&#x00F1;a&#x20;deja&#x20;de&#x20;vacunar&#x20;con&#x20;AstraZeneca&#x20;a&#x20;los&#x20;menores&#x20;de&#x20;60&#x3A;&#x20;los&#x20;que&#x20;ya&#x20;han&#x20;recibido&#x20;una&#x20;dosis&#x20;son&#x20;el&#x20;gran&#x20;problema&#x20;a&#x20;solucionar\" src=\"https:\/\/i.blogs.es\/25bb79\/doctor-5985533_640\/375_142.png\"><br \/>\n    <\/a>\n   <\/div>\n<div class=\"desvio-summary\">\n<div class=\"desvio-taxonomy js-desvio-taxonomy\">\n     <a href=\"https:\/\/www.xataka.com\/medicina-y-salud\/espana-deja-vacunar-astrazeneca-a-menores-60-nadie-sabe-que-ocurrira-que-han-recibido-dosis\" class=\"desvio-taxonomy-anchor m-crosspost\" >In Xataka<\/a>\n    <\/div>\n<p>    <a href=\"https:\/\/www.xataka.com\/medicina-y-salud\/espana-deja-vacunar-astrazeneca-a-menores-60-nadie-sabe-que-ocurrira-que-han-recibido-dosis\" class=\"desvio-title js-desvio-title\" >Spain stops vaccinating those under 60 with AstraZeneca: those who have already received a dose are the big problem to solve<\/a>\n   <\/div><\/div><\/div>\n<\/div>\n<p>The review included 273 patients (61.5% men), mean age 60 \u00b1 15 years. The average stay was 18 \u00b1 17 days. The incidence of thrombocytopenia was 2.26%. The most involved services were Hematology (56), Intensive Medicine (48) and Oncology (40). Thrombocytopenia was moderate in 69% of the cases, in 26 in % mild and in 5% severe.<\/p>\n<p><!-- BREAK 6 --><\/p>\n<p>There were 8 cases of drug-induced thrombocytopenia (incidence 0.063%), resolved in a mean of 7.6 days. Related medications were enoxaparin (2), linezolid (2), tacrolimus (2), thymoglobulin (1), and heparin (1). The doctor was recommended to suspend the drug (2), reduce the dose (3) or monitor it (3), with an acceptance of 100%. <\/p>\n<p><!-- BREAK 7 --><\/p>\n<div class=\"article-asset article-asset-normal article-asset-center\">\n<div class=\"desvio-container\">\n<div class=\"desvio\">\n<div class=\"desvio-figure js-desvio-figure\">\n    <a href=\"https:\/\/www.xataka.com\/medicina-y-salud\/esta-claro-que-hay-vinculo-vacuna-responsable-ema-confirma-vinculo-astrazeneca-trombos-visperas-nuevo-informe-europeo\"  ><br \/>\n     <img decoding=\"async\" alt=\"&quot;Est&#x00E1;&#x20;claro&#x20;que&#x20;hay&#x20;un&#x20;v&#x00ED;nculo&#x20;con&#x20;la&#x20;vacuna&quot;&#x3A;&#x20;un&#x20;responsable&#x20;de&#x20;la&#x20;EMA&#x20;confirma&#x20;el&#x20;v&#x00ED;nculo&#x20;entre&#x20;AstraZeneca&#x20;y&#x20;los&#x20;trombos&#x20;en&#x20;v&#x00ED;speras&#x20;de&#x20;un&#x20;nuevo&#x20;informe&#x20;europeo\" src=\"https:\/\/i.blogs.es\/9be186\/1366_2000\/375_142.jpg\"><br \/>\n    <\/a>\n   <\/div>\n<div class=\"desvio-summary\">\n<div class=\"desvio-taxonomy js-desvio-taxonomy\">\n     <a href=\"https:\/\/www.xataka.com\/medicina-y-salud\/esta-claro-que-hay-vinculo-vacuna-responsable-ema-confirma-vinculo-astrazeneca-trombos-visperas-nuevo-informe-europeo\" class=\"desvio-taxonomy-anchor m-crosspost\" >In Xataka<\/a>\n    <\/div>\n<p>    <a href=\"https:\/\/www.xataka.com\/medicina-y-salud\/esta-claro-que-hay-vinculo-vacuna-responsable-ema-confirma-vinculo-astrazeneca-trombos-visperas-nuevo-informe-europeo\" class=\"desvio-title js-desvio-title\" >&quot;Est\u00e1 claro que hay un v\u00ednculo con la vacuna&quot;: un responsable de la EMA confirma el v\u00ednculo entre AstraZeneca y los trombos en v\u00edsperas de un nuevo informe europeo<\/a>\n   <\/div><\/div><\/div>\n<\/div>\n<p>However, <strong>The most common drug involved in DITP is usually heparin<\/strong>. Life-threatening thromboembolic complications are common in patients with <a href=\"http:\/\/scielo.isciii.es\/scielo.php?script=sci_arttext&#038;pid=S1130-63432013000100005\">heparin-induced thrombocytopenia<\/a> (TIH). Thrombocytopenia may occur in 10 to 30% of heparin-treated patients in the absence of obvious immune system involvement. <\/p>\n<p><!-- BREAK 8 --><\/p>\n<p>The incidence of TCPIF is not known exactly, since case notification is voluntary and no studies designed for this purpose have been carried out. Based on various epidemiological studies in the United States and Europe, the minimum estimated incidence is around 10 cases per million inhabitants\/year.<\/p>\n<p><!-- BREAK 9 --><\/p>\n<div class=\"article-asset article-asset-normal article-asset-center\">\n<div class=\"desvio-container\">\n<div class=\"desvio\">\n<div class=\"desvio-figure js-desvio-figure\">\n    <a href=\"https:\/\/www.xataka.com\/medicina-y-salud\/como-ha-calculado-ema-que-beneficios-vacunar-astrazaneca-superan-mucho-riesgos-grupos-edad\"  ><br \/>\n     <img decoding=\"async\" alt=\"C&#x00F3;mo&#x20;ha&#x20;calculado&#x20;la&#x20;EMA&#x20;que&#x20;los&#x20;beneficios&#x20;de&#x20;vacunar&#x20;con&#x20;Astrazaneca&#x20;superan&#x20;por&#x20;mucho&#x20;los&#x20;riesgos&#x20;por&#x20;grupos&#x20;de&#x20;edad\" src=\"https:\/\/i.blogs.es\/66322e\/vaccine-6109178_640\/375_142.jpg\"><br \/>\n    <\/a>\n   <\/div>\n<div class=\"desvio-summary\">\n<div class=\"desvio-taxonomy js-desvio-taxonomy\">\n     <a href=\"https:\/\/www.xataka.com\/medicina-y-salud\/como-ha-calculado-ema-que-beneficios-vacunar-astrazaneca-superan-mucho-riesgos-grupos-edad\" class=\"desvio-taxonomy-anchor m-crosspost\" >In Xataka<\/a>\n    <\/div>\n<p>    <a href=\"https:\/\/www.xataka.com\/medicina-y-salud\/como-ha-calculado-ema-que-beneficios-vacunar-astrazaneca-superan-mucho-riesgos-grupos-edad\" class=\"desvio-title js-desvio-title\" >How the EMA has calculated that the benefits of vaccinating with Astrazaneca far outweigh the risks by age group<\/a>\n   <\/div><\/div><\/div>\n<\/div>\n<p>On the other hand, the incidence of TCPIF varies depending on the medications, with values from 5% to 40% in patients receiving heparin, while for other drugs it is lower than 1%. The drugs that have been most frequently related to the appearance of TCPIF are Cinchona alkaloids (quinine\/quinidine), sulfonamides, NSAIDs, diuretics, anticonvulsants and tuberculostatics.<\/p>\n<p><!-- BREAK 10 --><script>\n (function() {\n  window._JS_MODULES = window._JS_MODULES || {};\n  var headElement = document.getElementsByTagName('head')[0];\n  if (_JS_MODULES.instagram) {\n   var instagramScript = document.createElement('script');\n   instagramScript.src = 'https:\/\/platform.instagram.com\/en_US\/embeds.js';\n   instagramScript.async = true;\n   instagramScript.defer = true;\n   headElement.appendChild(instagramScript);\n  }\n })();\n<\/script><\/p>\n<p> &#8211; <br \/> The news<br \/>\n      <a href=\"https:\/\/www.xatakaciencia.com\/medicina\/300-medicamentos-pueden-causar-trombosis-muchos-ellos-mayor-probabilidad-que-astrazeneca?utm_source=feedburner&#038;utm_medium=feed&#038;utm_campaign=08_Apr_2021\"><br \/>\n       <em> More than 300 drugs can cause thrombosis, many of them more likely than AstraZeneca <\/em><br \/>\n      <\/a><br \/>\n      was originally published in<br \/>\n      <a href=\"https:\/\/www.xatakaciencia.com\/?utm_source=feedburner&#038;utm_medium=feed&#038;utm_campaign=08_Apr_2021\"><br \/>\n       <strong> Xataka Science <\/strong><br \/>\n      <\/a><br \/>\n            by <a\n       href=\"https:\/\/www.xatakaciencia.com\/autor\/sergio-parra?utm_source=feedburner&#038;utm_medium=feed&#038;utm_campaign=08_Apr_2021\"><br \/>\n       Sergio Parra<br \/>\n      <\/a><br \/>\n      . <\/p>\n<p><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/xatakaciencia\/~4\/3nxnXI6Xht8\" height=\"1\" width=\"1\" alt=\"\"\/><\/p>","protected":false},"excerpt":{"rendered":"<p>\n      <img decoding=\"async\" src=\"https:\/\/i.blogs.es\/06bfd9\/coronavirus-6119178_640\/1024_2000.png\" alt=\"M\u00e1s de 300 medicamentos pueden causar trombosis, muchos de ellos con mayor probabilidad que AstraZeneca\"><\/p>\n<p>Following the suspicions that thrombosis has been raised after the administration of the AstraZeneca vaccine, it is worth remembering that several hundred drugs have been linked to the <strong>drug-induced thrombocytopenia<\/strong> (TCPIF). TCPIF patients have a decrease in platelet count 5 to 10 days after drug administration with an increased risk of bleeding. <\/p>\n<p><!-- BREAK 1 --><\/p>\n<p>Diagnosis, furthermore, is often challenging, because most hospitalized patients take multiple medications and have comorbidities that can also cause thrombocytopenia.<\/p>\n<p><!-- BREAK 2 --><!--more--><\/p>\n<h2>Heparin<\/h2>\n<p>The European Medicines Agency (EMA) has announced that <a href=\"https:\/\/www.ema.europa.eu\/en\/news\/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood\">it is possible to associate<\/a> rare cases of blood clots and low levels of blood platelets with the AstraZeneca vaccine, so it should appear as a &quot;very rare&quot; side effect, with a probability of &lt;1\/10,000.<\/p>\n<p><!-- BREAK 3 --><\/p>\n<div class=\"article-asset-video article-asset-large\">\n<div class=\"asset-content\">\n<div class=\"base-asset-video\">\n<div class=\"js-dailymotion\">\n    <\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<p>The first cases of thrombosis after vaccination with AstraZeneca <strong>were detected between 3 and 14 days after dosing<\/strong>. The patients presented a &quot;very intense headache that worsened when lying down and did not improve with analgesics&quot;, there were even cases that also presented &quot;vomiting or irregular bleeding.&quot; This last condition is what is known clinically as thrombocytopenia.<\/p>\n<p><!-- BREAK 4 --><\/p>\n<p><strong>More than 300 drugs have been implicated in TCPIF<\/strong>. A <a href=\"https:\/\/ashpublications.org\/hematology\/article\/2018\/1\/576\/277620\/Drug-associated-thrombocytopenia\">systematic review<\/a> of individual patient data found that the most frequently reported drugs with a definite or probable causal relationship with thrombocytopenia were quinine, quinidine, trimethoprim\/sulfamethoxazole, vancomycin, penicillin, rifampin, carbamazepine, ceftriaxone, ibuprofen, mirtazapine, oxaliplatin. as well as the glycoprotein IIb\/IIIa (GPIIb\/IIa) inhibitors abciximab, Tirofiban, and eptifibatide.<\/p>\n<p><!-- BREAK 5 --><\/p>\n<div class=\"article-asset article-asset-normal article-asset-center\">\n<div class=\"desvio-container\">\n<div class=\"desvio\">\n<div class=\"desvio-figure js-desvio-figure\">\n    <a href=\"https:\/\/www.xataka.com\/medicina-y-salud\/espana-deja-vacunar-astrazeneca-a-menores-60-nadie-sabe-que-ocurrira-que-han-recibido-dosis\" target='\"_blank\"' rel=\"noopener\"><br \/>\n     <img decoding=\"async\" alt=\"Espa\u00f1a deja de vacunar con AstraZeneca a los menores de 60: los que ya han recibido una dosis son el gran problema a solucionar\" src=\"https:\/\/i.blogs.es\/25bb79\/doctor-5985533_640\/375_142.png\"><\/a>\n   <\/div>\n<div class=\"desvio-summary\">\n<div class=\"desvio-taxonomy js-desvio-taxonomy\">\n     <a href=\"https:\/\/www.xataka.com\/medicina-y-salud\/espana-deja-vacunar-astrazeneca-a-menores-60-nadie-sabe-que-ocurrira-que-han-recibido-dosis\" class=\"desvio-taxonomy-anchor m-crosspost\" target='\"_blank\"' rel=\"noopener\">In Xataka<\/a>\n    <\/div>\n<p>    <a href=\"https:\/\/www.xataka.com\/medicina-y-salud\/espana-deja-vacunar-astrazeneca-a-menores-60-nadie-sabe-que-ocurrira-que-han-recibido-dosis\" class=\"desvio-title js-desvio-title\" target='\"_blank\"' rel=\"noopener\">Spain stops vaccinating those under 60 with AstraZeneca: those who have already received a dose are the big problem to solve<\/a>\n   <\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<p>The review included 273 patients (61.5% men), mean age 60 \u00b1 15 years. The average stay was 18 \u00b1 17 days. The incidence of thrombocytopenia was 2.26%. The most involved services were Hematology (56), Intensive Medicine (48) and Oncology (40). Thrombocytopenia was moderate in 69% of the cases, in 26 in % mild and in 5% severe.<\/p>\n<p><!-- BREAK 6 --><\/p>\n<p>There were 8 cases of drug-induced thrombocytopenia (incidence 0.063%), resolved in a mean of 7.6 days. Related medications were enoxaparin (2), linezolid (2), tacrolimus (2), thymoglobulin (1), and heparin (1). The doctor was recommended to suspend the drug (2), reduce the dose (3) or monitor it (3), with an acceptance of 100%. <\/p>\n<p><!-- BREAK 7 --><\/p>\n<div class=\"article-asset article-asset-normal article-asset-center\">\n<div class=\"desvio-container\">\n<div class=\"desvio\">\n<div class=\"desvio-figure js-desvio-figure\">\n    <a href=\"https:\/\/www.xataka.com\/medicina-y-salud\/esta-claro-que-hay-vinculo-vacuna-responsable-ema-confirma-vinculo-astrazeneca-trombos-visperas-nuevo-informe-europeo\" target='\"_blank\"' rel=\"noopener\"><br \/>\n     <img decoding=\"async\" alt='\"Est\u00e1 claro que hay un v\u00ednculo con la vacuna\": un responsable de la EMA confirma el v\u00ednculo entre AstraZeneca y los trombos en v\u00edsperas de un nuevo informe europeo' src=\"https:\/\/i.blogs.es\/9be186\/1366_2000\/375_142.jpg\"><\/a>\n   <\/div>\n<div class=\"desvio-summary\">\n<div class=\"desvio-taxonomy js-desvio-taxonomy\">\n     <a href=\"https:\/\/www.xataka.com\/medicina-y-salud\/esta-claro-que-hay-vinculo-vacuna-responsable-ema-confirma-vinculo-astrazeneca-trombos-visperas-nuevo-informe-europeo\" class=\"desvio-taxonomy-anchor m-crosspost\" target='\"_blank\"' rel=\"noopener\">In Xataka<\/a>\n    <\/div>\n<p>    <a href=\"https:\/\/www.xataka.com\/medicina-y-salud\/esta-claro-que-hay-vinculo-vacuna-responsable-ema-confirma-vinculo-astrazeneca-trombos-visperas-nuevo-informe-europeo\" class=\"desvio-title js-desvio-title\" target='\"_blank\"' rel=\"noopener\">\u201cIt is clear that there is a link with the vaccine\u201d: an EMA official confirms the link between AstraZeneca and blood clots on the eve of a new European report<\/a>\n   <\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<p>However, <strong>The most common drug involved in DITP is usually heparin<\/strong>. Life-threatening thromboembolic complications are common in patients with <a href=\"http:\/\/scielo.isciii.es\/scielo.php?script=sci_arttext&amp;pid=S1130-63432013000100005\">heparin-induced thrombocytopenia<\/a> (TIH). Thrombocytopenia may occur in 10 to 30% of heparin-treated patients in the absence of obvious immune system involvement. <\/p>\n<p><!-- BREAK 8 --><\/p>\n<p>The incidence of TCPIF is not known exactly, since case notification is voluntary and no studies designed for this purpose have been carried out. Based on various epidemiological studies in the United States and Europe, the minimum estimated incidence is around 10 cases per million inhabitants\/year.<\/p>\n<p><!-- BREAK 9 --><\/p>\n<div class=\"article-asset article-asset-normal article-asset-center\">\n<div class=\"desvio-container\">\n<div class=\"desvio\">\n<div class=\"desvio-figure js-desvio-figure\">\n    <a href=\"https:\/\/www.xataka.com\/medicina-y-salud\/como-ha-calculado-ema-que-beneficios-vacunar-astrazaneca-superan-mucho-riesgos-grupos-edad\" target='\"_blank\"' rel=\"noopener\"><br \/>\n     <img decoding=\"async\" alt=\"C\u00f3mo ha calculado la EMA que los beneficios de vacunar con Astrazaneca superan por mucho los riesgos por grupos de edad\" src=\"https:\/\/i.blogs.es\/66322e\/vaccine-6109178_640\/375_142.jpg\"><\/a>\n   <\/div>\n<div class=\"desvio-summary\">\n<div class=\"desvio-taxonomy js-desvio-taxonomy\">\n     <a href=\"https:\/\/www.xataka.com\/medicina-y-salud\/como-ha-calculado-ema-que-beneficios-vacunar-astrazaneca-superan-mucho-riesgos-grupos-edad\" class=\"desvio-taxonomy-anchor m-crosspost\" target='\"_blank\"' rel=\"noopener\">In Xataka<\/a>\n    <\/div>\n<p>    <a href=\"https:\/\/www.xataka.com\/medicina-y-salud\/como-ha-calculado-ema-que-beneficios-vacunar-astrazaneca-superan-mucho-riesgos-grupos-edad\" class=\"desvio-title js-desvio-title\" target='\"_blank\"' rel=\"noopener\">How the EMA has calculated that the benefits of vaccinating with Astrazaneca far outweigh the risks by age group<\/a>\n   <\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<p>On the other hand, the incidence of TCPIF varies depending on the medications, with values from 5% to 40% in patients receiving heparin, while for other drugs it is lower than 1%. The drugs that have been most frequently related to the appearance of TCPIF are Cinchona alkaloids (quinine\/quinidine), sulfonamides, NSAIDs, diuretics, anticonvulsants and tuberculostatics.<\/p>\n<p><!-- BREAK 10 --><\/p>\n<p> &#8211; <br \/> The news<br \/>\n      <a href=\"https:\/\/www.xatakaciencia.com\/medicina\/300-medicamentos-pueden-causar-trombosis-muchos-ellos-mayor-probabilidad-que-astrazeneca?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=08_Apr_2021\"><br \/>\n       <em> More than 300 drugs can cause thrombosis, many of them more likely than AstraZeneca <\/em><br \/>\n      <\/a><br \/>\n      was originally published in<br \/>\n      <a href=\"https:\/\/www.xatakaciencia.com\/?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=08_Apr_2021\"><br \/>\n       <strong> Xataka Science <\/strong><br \/>\n      <\/a><br \/>\n            by <a href=\"https:\/\/www.xatakaciencia.com\/autor\/sergio-parra?utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=08_Apr_2021\"><br \/>\n       Sergio Parra<br \/>\n      <\/a><br \/>\n      . <\/p>\n<p><img decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/xatakaciencia\/~4\/3nxnXI6Xht8\" height=\"1\" width=\"1\" alt=\"\"><\/p>","protected":false},"author":19,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[125],"tags":[],"class_list":{"0":"post-36575","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-portal-3"},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/posts\/36575","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/comments?post=36575"}],"version-history":[{"count":7,"href":"https:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/posts\/36575\/revisions"}],"predecessor-version":[{"id":36988,"href":"https:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/posts\/36575\/revisions\/36988"}],"wp:attachment":[{"href":"https:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/media?parent=36575"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/categories?post=36575"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/forocilac.org\/en\/wp-json\/wp\/v2\/tags?post=36575"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}